Breast cancer accounts for a quarter of female cancers and has four intrinsic subtypes (luminal A, luminal B, HER2 positive and triple-negative) based on the status of the hormone receptor (HR) and human epithelial growth factor receptor 2 (HER2) [1, 2]. Here, ERBB2 is linked to breast cancer.